As reported in Figure 7B, we found that newly diagnosed B-ALL patients only expressed p53 after IO treatment, while three (R1, R5, and R6) of the four r/r B-ALL subjects in our series displayed p53 overexpression in the untreated condition suggesting the presence of a mutant p53. This evidence concerns the gene TP53 and precursor B-cell acute lymphoblastic leukemia.